ALLO CIK: 1737287

Allogene Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−185
FY22:
−221
FY23:
−238
FY24:
−200
FY25:
−149
Change from FY21 to FY25
millions USD
FY21:
164
FY22:
106
FY23:
163
FY24:
75.7
FY25:
95.6
Change from FY21 to FY25
millions USD
FY21:
12.0
FY22:
2.95
FY23:
95.7
FY24:
117
FY25:
30.2
millions USD
FY21:
−9.19
FY22:
−111
FY23:
21.3
FY24:
−7.94
FY25:
−23.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−206
FY22:
−226
FY23:
−239
FY24:
−201
FY25:
−150

All amounts in millions USD Data source:SEC EDGAR